Search

Daniel Siegwart, Ph.D., Professor in the Departments of Biomedical Engineering and Biochemistry and in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, has been selected as a fellow of the National Academy of Inventors (NAI) in recognition of his efforts in materials chemistry to enable targeted nanoparticle delivery of genomic medicines.

While the holiday season can bring joy to people of all ages, it also leaves many feeling depressed and lonely. Those who already suffer from a mental health condition can develop more serious symptoms. According to a survey by the National Alliance on Mental Illness (NAMI), 64% of people who have mental illness say their symptoms become worse when the winter holidays arrive.

This season of office parties and extravagant meals is filled with tempting treats that can make it difficult to reach your health goals.

A newly discovered “timekeeper” for fighting infections dramatically shapes the body’s immune defenses.

Researchers at UT Southwestern Medical Center have discovered how a hormone interacts with a receptor on the surface of immune cells to shield cancer cells from the body’s natural defenses. The findings, published in Nature Immunology, could lead to new immunotherapy approaches for treating cancer as well as potential treatments for inflammatory disorders and neurologic diseases.

A novel clinical pilot program at UT Southwestern Medical Center is transforming the role of nutrition education in patient care.

Artificial intelligence (AI) has become a go-to tool in health care, helping clinicians such as radiologists make diagnoses and personalize care. But what do patients think about this?

Zhijian “James” Chen, Ph.D., Professor in the Department of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on innate immunity, has been awarded the 2026 Elaine Redding Brinster Prize in Science or Medicine.

A team led by UT Southwestern Medical Center scientists has identified early signals from the immune system that could help predict which cancer patients are most likely to develop harmful side effects from immunotherapy.

The Liver Tumor Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has been selected by the National Cancer Institute as a Specialized Program of Research Excellence (SPORE).